Application Sponsors
ANDA 076781 | HIKMA FARMACEUTICA | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | EQ 2MG BASE/ML | 0 | ONDANSETRON HYDROCHLORIDE | ONDANSETRON HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2006-12-26 | |
LABELING; Labeling | SUPPL | 7 | AP | 2011-01-31 | |
LABELING; Labeling | SUPPL | 9 | AP | 2012-04-30 | |
LABELING; Labeling | SUPPL | 10 | AP | 2013-09-19 | STANDARD |
LABELING; Labeling | SUPPL | 11 | AP | 2014-12-20 | STANDARD |
LABELING; Labeling | SUPPL | 12 | AP | 2014-12-20 | STANDARD |
Submissions Property Types
SUPPL | 7 | Null | 7 |
SUPPL | 9 | Null | 15 |
SUPPL | 10 | Null | 15 |
SUPPL | 11 | Null | 7 |
SUPPL | 12 | Null | 7 |
TE Codes
CDER Filings
HIKMA FARMACEUTICA
cder:Array
(
[0] => Array
(
[ApplNo] => 76781
[companyName] => HIKMA FARMACEUTICA
[docInserts] => ["",""]
[products] => [{"drugName":"ONDANSETRON HYDROCHLORIDE","activeIngredients":"ONDANSETRON HYDROCHLORIDE","strength":"EQ 2MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ONDANSETRON HYDROCHLORIDE","submission":"ONDANSETRON HYDROCHLORIDE","actionType":"EQ 2MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)